Inavir (laninamivir octanoate)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Inavir (laninamivir octanoate), covering 2017-09-01 to 2025-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza [Phase 1, Phase 2]